OBAGI-C RX SYSTEM C-SUNGUARD description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

OBAGI-C RX SYSTEM C-SUNGUARD

OMP, INC.

OBAGI-C™ RX SYSTEM


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

Drug Facts

Active ingredients

Octinoxate, 7.5%, Zinc oxide, 9%

Purpose

Sunscreens

OBAGI-C RX SYSTEM C-SUNGUARD Uses

  • Helps prevent sunburn.
  • Higher SPF gives more sunburn protection.

Warnings

  • For external use only.

When using this product

  • Keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if

  • Rash or irritation develops and lasts.

Keep out of the reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • Apply generously and evenly 15 minutes before sun exposure.
  • Children under six months of age: ask a doctor.
  • Reapply as needed or after towel drying, swimming or perspiring.

OBAGI-C RX SYSTEM C-SUNGUARD Other information

  • Store at controlled room temperature: 15°-30°C (59°-86°F).
  • High sun protection product.
  • Sun alert: Limiting sun exposure, wearing protective clothing, and using sunscreens may reduce the risks of skin aging, skin cancer, and other harmful effects of the sun.

Inactive ingredients

butylparaben, cetearyl alcohol, citric acid, C13-14 isoparaffin, diethanolamine cetyl phosphate, disodium edetate, ethylparaben, isobutylparaben, isopropyl palmitate, laureth-7, methylparaben, octyl stearate, phenoxyethanol, polyacrylamide, polyether-1, polysorbate 60, propylparaben, purified water, sodium hydroxide, triethoxycaprylysilane.

Dist. by OMP, Inc. Long Beach, CA 90802

PRINCIPAL DISPLAY PANEL - 90 mL Bottle Carton

OBAGI-C
RX SYSTEM

RECOMMENDED
SKIN
CANCER
FOUNDATION

RECOMMENDED AS AN
EFFECTIVE UV SUNSCREEN

C-SUNGUARD
SPF 30

BROAD-SPECTRUM
UVA / UVB SUNSCREEN

AM

3 FL. OZ. (90 mL)

OBAGI-C RX SYSTEM C-SUNGUARD

OBAGI-C RX SYSTEM C-SUNGUARD

OCTINOXATE and ZINC OXIDE CREAM

Product Information

Product Type Human otc drug label Item Code (Source) NDC:62032-107
Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
OCTINOXATE OCTINOXATE 75 mg
Zinc Oxide Zinc oxide 90 mg

Inactive Ingredients

Ingredient Name Strength
ISOPROPYL PALMITATE
water
ETHYLHEXYL STEARATE
CETOSTEARYL ALCOHOL
POLYSORBATE 60
C13-14 ISOPARAFFIN
METHYLPARABEN
LAURETH-7
PROPYLPARABEN
EDETATE DISODIUM
BUTYLPARABEN
DIETHANOLAMINE CETYL PHOSPHATE
PHENOXYETHANOL
ETHYLPARABEN
isobutylparaben
SODIUM HYDROXIDE
TRIETHOXYCAPRYLYLSILANE
CITRIC ACID MONOHYDRATE

Product Characteristics

Color
WHITE

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 90 in 1 BOTTLE, PLASTIC
2 NDC:62032-107-90 1 in 1 CARTON

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
part part352 2002-01-01


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.